Search Results
Slidesets
HIV-1/HCV co-infection treatment with single-tablet antiviral regimens (CoSTARs): 12 Weeks of Ledipasvir/ Sofosbuvir (LDV/SOF) after randomized switch to Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir alafenamide (E/C/F/TAF) or rilpivirin- Damian Mccoll
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2018
Abstracts
International Transmission Clusters of Acute Hepatitis C Virus Among Men Who Have Sex With Men in the Netherlands. A phylogenetic analysis.
D. Vijver
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Strategies for population-based screening and treatment of hepatitis B in sub-Saharan Africa: a mathematical modelling study in The Gambia
N. Schmit
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Significant life events and viral suppression outcomes in children starting antiretroviral therapy in South Africa
J. Cambeiro
Reviews in Antiviral Therapy & Infectious Diseases 9, 2020
Presented at:
International Workshop on HIV Pediatrics 2020
Abstracts
Usability of a Mobile Health Application (“APP”) on older HIV-Infected Patients: An emerging tool for care, education and prevention
Presented at:
European Workshop on Healthy Living with HIV 2019
Slidesets
Hepatitis B screening and prevention integration into ante-natal care and delivery services in an urban cohort in Mozambique- Natalia Tamayo Antabak
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Discussion: What constitutes “Adolescent Friendly” Programming?- Catherine Dollfus, MD, MPH
Presented at:
International Workshop on HIV & Pediatrics 2017
Slidesets
PrEP On-Demand vs Conventional - Esper Kallas
Presented at:
Salvador HIV Clinical Forum 2022